Astellas Pharma Share Holder Equity 2012-2024 | ALPMY

Astellas Pharma share holder equity for the quarter ending June 30, 2024 was $10.729B, a 11.71% decline year-over-year.

  • Astellas Pharma share holder equity for 2024 was $10.569B, a 6.78% decline from 2023.
  • Astellas Pharma share holder equity for 2023 was $11.338B, a 5.28% decline from 2022.
  • Astellas Pharma share holder equity for 2022 was $11.97B, a 4.15% decline from 2021.

Astellas Pharma Share Holder Equity 2012-2024 | ALPMY

  • Astellas Pharma share holder equity for 2024 was $10.569B, a 6.78% decline from 2023.
  • Astellas Pharma share holder equity for 2023 was $11.338B, a 5.28% decline from 2022.
  • Astellas Pharma share holder equity for 2022 was $11.97B, a 4.15% decline from 2021.